June 2, 2020 / 9:12 PM / a month ago

BRIEF-Summit Therapeutics Posts Q1 Loss Per Share From Operations Of $0.02

June 2 (Reuters) - Summit Therapeutics PLC:

* SUMMIT THERAPEUTICS REPORTS FINANCIAL RESULTS AND OPERATIONAL PROGRESS FOR THE FIRST QUARTER AND THREE MONTHS ENDED MARCH 31, 2020

* SUMMIT THERAPEUTICS PLC - QTRLY LOSS PER SHARE FROM OPERATIONS $0.02

* SUMMIT THERAPEUTICS PLC - CASH AND CASH EQUIVALENTS AT MARCH 31, 2020, OF $55.3 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below